New strains of Clostridium butyricum capable of producing butyric acid

TWI939892BActive Publication Date: 2026-09-21HIGHER MOUNT CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
TW113149137
Authority / Receiving Office
TW · TW
Patent Type
Patents
Current Assignee / Owner
Priority Date
2023-12-19
Filing Date
2024-12-17
Publication Date
2026-09-21
Estimated Expiration
2044-12-16

Smart Images

  • Figure TWG2TB001912009_001
    Figure TWG2TB001912009_001
  • Figure TWG2TB001912009_002
    Figure TWG2TB001912009_002
  • Figure TWG2TB001912009_003
    Figure TWG2TB001912009_003
Patent Text Reader

Abstract

The present invention aims to provide a butyric acid bacterium that can be used more safely as an effective ingredient in intestinal regulators, etc. The present invention relates to a Clostridium butyricum that produces orthobutyric acid and has all the following characteristics (1) to (3): (1) it does not have the ability to assimilate D-xylose; (2) it does not have the ability to assimilate D-trehalose; (3) compared with the baseline strain of Clostridium butyricum NBRC13949T, the amount of formic acid produced in the culture medium after anaerobic culture at 37°C for 72 hours is less.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A Clostridium butyricum strain SIID29215-B6 (accession number: NITE BP-03916).

2. A Clostridium butyricum strain SIID49520-01-B1 (accession number: NITE BP-04190).

3. A Clostridium butyricum strain SIID50030-B1 (accession number: NITE BP-04191).

4. An intestinal regulating composition comprising, as an active ingredient, Clostridium butyricum cells, spores or culture medium as claimed in any one of claims 1 to 3.

5. A composition for inhibiting the growth of Clostridium difficile, comprising, as an active ingredient, the cells, spores or culture medium of Clostridium butyricum as claimed in any one of claims 1 to 3.

6. An anti-inflammatory composition comprising, as an active ingredient, Clostridium butyricum cells, spores or culture medium as claimed in any one of claims 1 to 3.

7. A composition for inducing regulatory T cells, comprising, as an active ingredient, Clostridium butyricum cells, spores or culture medium as claimed in any one of claims 1 to 3.

8. The components of claim 4 are in the form of a pharmaceutical product.

9. The components of claim 5 are in the form of a pharmaceutical product.

10. The components of claim 6 are in the form of a pharmaceutical product.

11. As in claim 7, the composition is in the form of a pharmaceutical product.

12. As in claim 4, the components are in the form of food or beverage.

13. As in claim 5, the composition is in the form of food or beverage.

14. As in claim 6, the composition is in the form of food or beverage.

15. As in claim 7, the composition is in the form of food or beverage.

Citation Information

Patent Citations

  • Novel microorganism

    JP2022158555A

  • Butyric acid-producing bacterium

    WO2017033925A1